Temps Différé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
- CAD | -.--% | -5,08% | +3,70% |
2020 | Transcript : Correvio Pharma Corp. - Shareholder/Analyst Call | |
2019 | Transcript : Correvio Pharma Corp., Q3 2019 Earnings Call, Nov 14, 2019 |
CA 2018 | 28,67 M 39,2 M 25,96 M | CA 2019 | 32,63 M 44,61 M 29,54 M | Capitalisation | 27,28 M 37,29 M 24,7 M |
---|---|---|---|---|---|
Résultat net 2018 | -16 M -21,87 M -14,48 M | Résultat net 2019 | -35 M -47,84 M -31,68 M | VE / CA 2018 | 5,13 x |
Dette nette 2018 | 25,92 M 35,43 M 23,47 M | Dette nette 2019 | 33,9 M 46,35 M 30,69 M | VE / CA 2019 | 1,87 x |
PER 2018 |
-7,1
x | PER 2019 |
-0,68
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 86,23% |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Ram Ramkumar
BRD | Director/Board Member | - | - |
Andreas Stickler
BRD | Director/Board Member | 53 | - |
Robert Ford
BRD | Director/Board Member | - | - |
Varia. 1 janv. | Capi. | |
---|---|---|
+3,70% | 27,65 M | |
+7,91% | 72,81 Md | |
-10,56% | 5,13 Md | |
+58,79% | 4,99 Md | |
+4,07% | 3,9 Md | |
-16,90% | 2,48 Md | |
+20,84% | 2,42 Md | |
-26,13% | 2,32 Md | |
+19,31% | 2,17 Md | |
-0,50% | 1,64 Md |